αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors
暂无分享,去创建一个
J. Changeux | R. Luján | A. Ferrer-Montiel | I. Devesa | Clotilde Ferrándiz-Huertas | S. Mathivanan | C. Wolf
[1] Keivan Basiri,et al. The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[2] Ya-Yun Wang,et al. A closer look to botulinum neurotoxin type A-induced analgesia. , 2013, Toxicon : official journal of the International Society on Toxinology.
[3] M. Zylka,et al. Peptidergic CGRPα Primary Sensory Neurons Encode Heat and Itch and Tonically Suppress Sensitivity to Cold , 2013, Neuron.
[4] V. Felipo,et al. An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain , 2012, Journal of Pharmacology and Experimental Therapeutics.
[5] D. J. Cavanaugh,et al. Restriction of Transient Receptor Potential Vanilloid-1 to the Peptidergic Subset of Primary Afferent Neurons Follows Its Developmental Downregulation in Nonpeptidergic Neurons , 2011, The Journal of Neuroscience.
[6] J. González-Ros,et al. Role of the transient receptor potential vanilloid 1 in inflammation and sepsis , 2011, Journal of inflammation research.
[7] Xu Zhang,et al. Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles , 2011, Cell Research.
[8] H. Diener,et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial , 2010, Cephalalgia : an international journal of headache.
[9] H. Diener,et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial , 2010, Cephalalgia : an international journal of headache.
[10] Manuela Schmidt,et al. Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane , 2009, Neuron.
[11] A. Ferrer-Montiel,et al. Differential contribution of SNARE‐dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] S. Ovsepian,et al. Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential , 2009, The Journal of Neuroscience.
[13] H. Koerber,et al. Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2 , 2008, PAIN.
[14] S. Jung,et al. Differential Changes in TRPV1 expression after trigeminal sensory nerve injury. , 2008, The journal of pain : official journal of the American Pain Society.
[15] M. Pauza,et al. Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons , 2008, Molecular Pharmacology.
[16] R. Ji,et al. Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKCε: A Novel Pathway for Heat Hyperalgesia , 2007, The Journal of Neuroscience.
[17] C. M. Flores,et al. Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. , 2007, The journal of pain : official journal of the American Pain Society.
[18] P. Anand,et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score , 2007, Journal of Clinical Neuroscience.
[19] N. Ziv,et al. Assembly of Active Zone Precursor Vesicles , 2006, Journal of Biological Chemistry.
[20] P. McNaughton,et al. NGF rapidly increases membrane expression of TRPV1 heat‐gated ion channels , 2005, The EMBO journal.
[21] K. Bölcskei,et al. Role of Transient Receptor Potential Vanilloid 1 Receptors in Adjuvant-Induced Chronic Arthritis: In Vivo Study Using Gene-Deficient Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[22] N. Carruthers,et al. Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.
[23] J. Changeux,et al. Analysis of the cellular expression pattern of β‐CGRP in α‐CGRP‐deficient mice , 2004, The Journal of comparative neurology.
[24] A. Ferrer-Montiel,et al. Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity* , 2004, Journal of Biological Chemistry.
[25] P. McNaughton,et al. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor , 2003, The Journal of physiology.
[26] T. Fukuoka,et al. Possible Involvement of P2Y2 Metabotropic Receptors in ATP-Induced Transient Receptor Potential Vanilloid Receptor 1-Mediated Thermal Hypersensitivity , 2003, The Journal of Neuroscience.
[27] N. Ziv,et al. Unitary Assembly of Presynaptic Active Zones from Piccolo-Bassoon Transport Vesicles , 2003, Neuron.
[28] J. Simpson,et al. Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse , 2002, The Journal of Neuroscience.
[29] M. Masu,et al. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] Eckart D. Gundelfinger,et al. Assembling the Presynaptic Active Zone A Characterization of an Active Zone Precursor Vesicle , 2001, Neuron.
[31] T. Sugimoto,et al. VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion , 2001, Brain Research.
[32] K. Westlund,et al. Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity , 2001, Pain.
[33] Jerilyn A. Walker,et al. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). , 2000, BioTechniques.
[34] A I Basbaum,et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.
[35] J. Changeux,et al. Modulation of morphine analgesia in αcgrp mutant mice , 1999 .
[36] R. Elde,et al. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites , 1999, The European journal of neuroscience.
[37] A. Basbaum,et al. The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli , 1998, Neuron.
[38] C. Epstein,et al. Primary afferent tachykinins are required to experience moderate to intense pain , 1998, Nature.
[39] H Bostock,et al. Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. , 1997, Journal of neurophysiology.
[40] W. Han,et al. Calcium sensing in exocytosis. , 2012, Advances in experimental medicine and biology.
[41] F. Qin,et al. Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. , 2011, Advances in experimental medicine and biology.
[42] Antonio Ferrer-Montiel,et al. Physiology and pharmacology of the vanilloid receptor. , 2006, Current neuropharmacology.
[43] D. Julius,et al. The vanilloid receptor: a molecular gateway to the pain pathway. , 2001, Annual review of neuroscience.
[44] J. Changeux,et al. Modulation of morphine analgesia in alphaCGRP mutant mice. , 1999, Neuroreport.